AstraZeneca Sues Mylan Over Fresh Asthma Drug Patent
After AstraZeneca obtained a drug patent related to asthma treatment Symbicort on Tuesday, the biopharmaceutical company wasted no time filing a patent suit the same day against Mylan and drug delivery...To view the full article, register now.
Already a subscriber? Click here to view full article